The Best Gut Lining Supplements: What the Evidence Actually Supports

L-Glutamine is the most abundant amino acid in the body and the primary fuel for intestinal epithelial cells, the cells that physically make up the gut lining. Approximately 70 per cent of orally consumed glutamine is taken up by the gut before it reaches the bloodstream. Under conditions of gut stress, infection, or microbiome disruption, demand for glutamine at the intestinal level increases significantly, and dietary intake alone often cannot meet it.

The clinical evidence for glutamine supplementation is strongest in people with documented intestinal permeability changes: post-infectious IBS, post-antibiotic recovery, and chronic gastritis, where a 2024 meta-analysis confirmed statistically significant permeability improvement at adequate doses in compromised populations. It is not a supplement that shows dramatic effects in people with healthy gut barriers; it is condition-specific and most effective when the lining genuinely needs the fuel.

Evidence-based dose: 5 g per day for daily long-term support; up to 15 g per day has been used in acute clinical trials. Standard supplement servings of 5 g are appropriate for ongoing use alongside a protein-containing diet.

Slippery elm (Ulmus rubra) is the inner bark of a North American tree, used traditionally for digestive discomfort long before its mechanism was studied. Like marshmallow root, it contains mucilaginous polysaccharides that form a viscous gel on contact with moisture, coating irritated mucosal surfaces and providing a physical buffer between the gut wall and its contents while the underlying tissue recovers.

Its demulcent action is distinct from the cellular-repair mechanisms of L-Glutamine or the mucus-stimulating action of DGL: rather than acting on the cells themselves, it works externally, reducing direct irritant contact with an already compromised lining. It is commonly paired with marshmallow root, since the two share a mechanism but are sourced from different plants, and combining them broadens the polysaccharide profile involved.

Typical dose: 400 to 1,000 mg daily, though ranges vary by preparation. As with marshmallow root, cold-extracted preparations preserve more of the mucilage-forming polysaccharides than hot water or alcohol-based extraction.

Deglycyrrhizinated licorice (DGL) is licorice root with the blood-pressure-raising glycyrrhizin compound removed, leaving the flavonoids responsible for its mucosal protective effects intact. Its primary mechanism is stimulating mucus-producing cells in the stomach and intestinal lining to produce more protective mucus. It also has direct anti-inflammatory activity in gastric and intestinal tissue, and promotes epithelial cell regeneration.

Unlike antacids and PPIs, DGL does not suppress acid. It builds the protective lining that acid has to get through before it reaches the epithelial cells beneath. Clinical comparisons have shown DGL producing ulcer healing rates comparable to cimetidine with lower relapse rates at follow-up, attributed to the difference between addressing mucosal protection versus suppressing acidity without addressing the barrier.

Evidence-based dose: 380–760 mg before meals. Best taken chewed before eating for oesophageal symptoms; swallowed for gastric and intestinal effects.

Marshmallow root (Althaea officinalis) contains up to 35 per cent mucilaginous polysaccharides by weight that form a viscous protective gel when they contact the moist mucosal surfaces of the gastrointestinal tract. This gel physically coats the gut lining, providing a temporary buffer between the tissue and luminal irritants such as acid, bile, digestive enzymes, and food particles, while the underlying repair processes work beneath it.

Beyond its coating action, marshmallow root polysaccharides have demonstrated anti-inflammatory activity in mucosal tissue and promote epithelial cell proliferation in vitro. Research has confirmed that the bioactive polysaccharides survive simulated gastric passage and reach the intestinal lining intact. It pairs particularly well with DGL, as the two cover complementary aspects of mucosal protection: DGL stimulates the body's own mucus production, while marshmallow root provides an external coating layer.

Evidence-based dose: 500 mg to 2 g of root extract before meals. Cold-extracted preparations preserve mucilage content better than hot water or alcohol extraction.

Butyrate is a short-chain fatty acid produced when gut bacteria ferment dietary fibre. It is the primary fuel source for colonocytes, the cells of the large intestinal lining, in the same way that glutamine is the primary fuel for small intestinal enterocytes. Without adequate butyrate, colonocyte energy metabolism is impaired and the integrity of the colon lining degrades. Butyrate also directly upregulates the expression of tight junction proteins and has systemic anti-inflammatory effects mediated through its action on immune cells in the gut wall.

Supplementally, butyrate is available as sodium butyrate or calcium-magnesium butyrate, often in enteric-coated or tributyrin forms to improve delivery past the stomach. Prebiotic fibres, specifically resistant starch, inulin, and fructooligosaccharides, increase butyrate production by feeding the butyrate-producing bacterial species in the colon. The combination of a spore-forming probiotic and prebiotic fibre is often more practical than butyrate supplementation alone for long-term colon lining support.

Evidence-based approach: Enteric-coated sodium butyrate 150–300 mg per day; or prebiotic fibre 5–10 g per day to support endogenous butyrate production.

A healthy, diverse gut microbiome is one of the most important contributors to gut lining integrity, and not through the probiotic organisms themselves directly repairing the lining, but through the butyrate production, competitive exclusion of pathogenic bacteria, immune signalling, and mucus layer support that a healthy microbial community provides. Post-antibiotic dysbiosis, H. pylori infection, and chronic intestinal inflammation all disrupt this ecosystem in ways that indirectly but significantly impair gut lining maintenance.

Bacillus coagulans spore probiotics are particularly well suited to gut lining support protocols because they survive gastric acid in their spore form and germinate in the intestine, where they produce lactic acid and antimicrobial compounds that support a healthy bacterial environment. They are significantly more stable than standard lactobacillus or bifidobacterium probiotics and do not require refrigeration, which means the dose that reaches the intestine matches the label dose reliably.

Evidence-based dose: At least 1 billion CFU per day, typically 2–3 billion CFU in clinical studies showing gut health benefits. Spore form is preferable for stability and reliability.